CureVac N.V.
CureVac N.V. (CVAC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CVAC · as of Jun 8, 2026
Key Statistics
Explore CureVac N.V. Data
cvac stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 25.0%
The CVAC analyst consensus is Hold, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $21.00, representing +350.64% upside from the current price of $4.66.
Competitors & Peers
cvac competitorsCVAC
AMLX
ELVN
IMTX
INBX
NKTRStock Performance
Full HistoryAbout CureVac N.V.
CureVac N.V. a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, suc…
what is curevac n.v. · cvac stock overview · curevac n.v. company profile · who is curevac n.v. ceo · cvac NASDAQ · curevac n.v. headquarters · curevac n.v. business segments
About Stock Overview & Key Data
CureVac N.V. (CVAC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 14, 2020. As of the latest trading session, CVAC stock price is $4.66, with a market capitalization of $1.0B. The stock has returned +23.61% over the past 12 months and -0.21% year-to-date.
According to 8 Wall Street analysts, the consensus rating for CureVac N.V. stock is Hold, with an average 12-month price target of $21.00. In fiscal year 2024, CureVac N.V. reported revenue of $535.2M and net income of $162.2M. For detailed data — including CureVac N.V. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CureVac N.V. (CVAC) stock price is $4.66. The stock is traded on NASDAQ under the ticker symbol CVAC. The 52-week range is $2.48 – $5.72.